| Roche Pharma (Schweiz) AG - Phesgo 600 mg/600 mg/10 ml, Injektionslösung | | 67828 | | 01 | | Phesgo 600 mg/600 mg/10 ml | | Injektionslösung | | L01FY01 | | | | 08.04.2021 | | |
| | Composition | | pertuzumabum 600 mg, trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 10 ml. | | Packungsbestandteile | | Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Pertuzumabum | 600mg / 10ml | | Trastuzumab | 600mg / 10ml |
| | BAG: Principe actif | Concentr. |
|---|
| Pertuzumabum | 600 mg | | Trastuzumab | 600 mg |
| | | | Agents auxilliaires |
|---|
| DL-Methionine | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Polysorbatum 20 | | Saccharum | | Trehalosum Dihydricum |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 3719.73 | 4061.85 | A | LS | Oui |
|
|
